ARTICLE | Distillery Therapeutics
Therapeutics: B cell lymphoma 11A (BCL11A)
February 19, 2015 8:00 AM UTC
In vitro and mouse studies suggest inhibiting BCL11A could help treat triple negative breast cancer (TNBC). In a screen of breast cancer subtypes, high BCL11A levels caused by overexpression or copy n...